APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Somatostatin

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.

Selected research

Market Structure

Global Somatostatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174036900322 December 2025190 pages

Choose your research edition.

Industry ResearchSomatostatin Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Somatostatin Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Somatostatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Somatostatin Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Somatostatin Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.

Global Somatostatin key players include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., HYBIO, etc. Global top five manufacturers hold a share over 65%.

China is the largest market, followed by Europe and India.

Read the full market overview

This report provides an overview of the global Somatostatin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Somatostatin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Somatostatin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Somatostatin market size, projected growth trends, production technologies, key applications, and end-use industries.

Somatostatin Segment by Company

Merck (Schweiz) AG

SANOFI-AVENTIS FRANCE

Lyomark Pharma GmbH

ALFA WASSERMANN S.p.A.

Polypeptide Laboratories, Inc

SAMARTH

UBPL

HYBIO

TianTaiShan

Yangtze River

Siyao

Shuangcheng

Hainan Zhonghe

SL PHARM

Wuhan Hualong

Qingdao Guoda

Chengdu Shengnuo

Longjin

Somatostatin Segment by Type

0.25mg/pcs

0.75mg/pcs

3mg/pcs

Somatostatin Segment by Application

Hormonal Disorder

Oncology

Metabolic Disorder

Others

Somatostatin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Somatostatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Somatostatin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Somatostatin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Somatostatin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Somatostatin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Somatostatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Somatostatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Somatostatin Industry Trends Table 2. Somatostatin Industry Drivers Table 3. Somatostatin Industry Opportunities and Challenges Table 4. Somatostatin Industry Restraints Table 5. Global Somatostatin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Somatostatin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Somatostatin Sales by Manufacturers (K Pcs) & (2021-2026) Table 8. Global Somatostatin Sales Market Share by Manufacturers Table 9. Global Somatostatin Average Sales Price (USD/Pcs) of Manufacturers (2021-2026) Table 10. Global Somatostatin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Somatostatin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Somatostatin Manufacturers, Product Type & Application Table 13. Global Somatostatin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Somatostatin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.25mg/pcs Table 17. Major Manufacturers of 0.75mg/pcs Table 18. Major Manufacturers of 3mg/pcs Table 19. Global Somatostatin Sales by Type 2021 VS 2025 VS 2032 (K Pcs) Table 20. Global Somatostatin Sales by Type (2021-2026) & (K Pcs) Table 21. Global Somatostatin Sales by Type (2027-2032) & (K Pcs) Table 22. Global Somatostatin Sales Market Share by Type (2021-2026) Table 23. Global Somatostatin Sales Market Share by Type (2027-2032) Table 24. Global Somatostatin Revenue by Type 2021 VS 2025 VS 2032 (K Pcs) Table 25. Global Somatostatin Revenue by Type (2021-2026) & (K Pcs) Table 26. Global Somatostatin Revenue by Type (2027-2032) & (K Pcs) Table 27. Global Somatostatin Revenue Market Share by Type (2021-2026) Table 28. Global Somatostatin Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hormonal Disorder Table 30. Major Manufacturers of Oncology Table 31. Major Manufacturers of Metabolic Disorder Table 32. Major Manufacturers of Others Table 33. Global Somatostatin Sales by Application 2021 VS 2025 VS 2032 (K Pcs) Table 34. Global Somatostatin Sales by Application (2021-2026) & (K Pcs) Table 35. Global Somatostatin Sales by Application (2027-2032) & (K Pcs) Table 36. Global Somatostatin Sales Market Share by Application (2021-2026) Table 37. Global Somatostatin Sales Market Share by Application (2027-2032) Table 38. Global Somatostatin Revenue by Application 2021 VS 2025 VS 2032 (K Pcs) Table 39. Global Somatostatin Revenue by Application (2021-2026) & (K Pcs) Table 40. Global Somatostatin Revenue by Application (2027-2032) & (K Pcs) Table 41. Global Somatostatin Revenue Market Share by Application (2021-2026) Table 42. Global Somatostatin Revenue Market Share by Application (2027-2032) Table 43. Global Somatostatin Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 44. Global Somatostatin Sales by Region (2021-2026) & (K Pcs) Table 45. Global Somatostatin Sales Market Share by Region (2021-2026) Table 46. Global Somatostatin Sales Forecasted by Region (2027-2032) & (K Pcs) Table 47. Global Somatostatin Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Somatostatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 49. North America Somatostatin Sales by Country (2021-2026) & (K Pcs) Table 50. North America Somatostatin Sales by Country (2027-2032) & (K Pcs) Table 51. Europe Somatostatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 52. Europe Somatostatin Sales by Country (2021-2026) & (K Pcs) Table 53. Europe Somatostatin Sales by Country (2027-2032) & (K Pcs) Table 54. Asia Pacific Somatostatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 55. Asia Pacific Somatostatin Sales by Country (2021-2026) & (K Pcs) Table 56. Asia Pacific Somatostatin Sales by Country (2027-2032) & (K Pcs) Table 57. South America, Middle East and Africa Somatostatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 58. South America, Middle East and Africa Somatostatin Sales by Country (2021-2026) & (K Pcs) Table 59. South America, Middle East and Africa Somatostatin Sales by Country (2027-2032) & (K Pcs) Table 60. Global Somatostatin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Somatostatin Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Somatostatin Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Somatostatin Revenue Market Share by Region (2021-2026) Table 64. Global Somatostatin Revenue Market Share by Region (2027-2032) Table 65. Merck (Schweiz) AG Company Information Table 66. Merck (Schweiz) AG Business Overview Table 67. Merck (Schweiz) AG Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Merck (Schweiz) AG Somatostatin Product Portfolio Table 69. Merck (Schweiz) AG Recent Development Table 70. SANOFI-AVENTIS FRANCE Company Information Table 71. SANOFI-AVENTIS FRANCE Business Overview Table 72. SANOFI-AVENTIS FRANCE Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. SANOFI-AVENTIS FRANCE Somatostatin Product Portfolio Table 74. SANOFI-AVENTIS FRANCE Recent Development Table 75. Lyomark Pharma GmbH Company Information Table 76. Lyomark Pharma GmbH Business Overview Table 77. Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Lyomark Pharma GmbH Somatostatin Product Portfolio Table 79. Lyomark Pharma GmbH Recent Development Table 80. ALFA WASSERMANN S.p.A. Company Information Table 81. ALFA WASSERMANN S.p.A. Business Overview Table 82. ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. ALFA WASSERMANN S.p.A. Somatostatin Product Portfolio Table 84. ALFA WASSERMANN S.p.A. Recent Development Table 85. Polypeptide Laboratories, Inc Company Information Table 86. Polypeptide Laboratories, Inc Business Overview Table 87. Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Polypeptide Laboratories, Inc Somatostatin Product Portfolio Table 89. Polypeptide Laboratories, Inc Recent Development Table 90. SAMARTH Company Information Table 91. SAMARTH Business Overview Table 92. SAMARTH Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. SAMARTH Somatostatin Product Portfolio Table 94. SAMARTH Recent Development Table 95. UBPL Company Information Table 96. UBPL Business Overview Table 97. UBPL Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. UBPL Somatostatin Product Portfolio Table 99. UBPL Recent Development Table 100. HYBIO Company Information Table 101. HYBIO Business Overview Table 102. HYBIO Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. HYBIO Somatostatin Product Portfolio Table 104. HYBIO Recent Development Table 105. TianTaiShan Company Information Table 106. TianTaiShan Business Overview Table 107. TianTaiShan Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. TianTaiShan Somatostatin Product Portfolio Table 109. TianTaiShan Recent Development Table 110. Yangtze River Company Information Table 111. Yangtze River Business Overview Table 112. Yangtze River Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Yangtze River Somatostatin Product Portfolio Table 114. Yangtze River Recent Development Table 115. Siyao Company Information Table 116. Siyao Business Overview Table 117. Siyao Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Siyao Somatostatin Product Portfolio Table 119. Siyao Recent Development Table 120. Shuangcheng Company Information Table 121. Shuangcheng Business Overview Table 122. Shuangcheng Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Shuangcheng Somatostatin Product Portfolio Table 124. Shuangcheng Recent Development Table 125. Hainan Zhonghe Company Information Table 126. Hainan Zhonghe Business Overview Table 127. Hainan Zhonghe Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Hainan Zhonghe Somatostatin Product Portfolio Table 129. Hainan Zhonghe Recent Development Table 130. SL PHARM Company Information Table 131. SL PHARM Business Overview Table 132. SL PHARM Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. SL PHARM Somatostatin Product Portfolio Table 134. SL PHARM Recent Development Table 135. Wuhan Hualong Company Information Table 136. Wuhan Hualong Business Overview Table 137. Wuhan Hualong Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Wuhan Hualong Somatostatin Product Portfolio Table 139. Wuhan Hualong Recent Development Table 140. Qingdao Guoda Company Information Table 141. Qingdao Guoda Business Overview Table 142. Qingdao Guoda Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Qingdao Guoda Somatostatin Product Portfolio Table 144. Qingdao Guoda Recent Development Table 145. Chengdu Shengnuo Company Information Table 146. Chengdu Shengnuo Business Overview Table 147. Chengdu Shengnuo Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Chengdu Shengnuo Somatostatin Product Portfolio Table 149. Chengdu Shengnuo Recent Development Table 150. Longjin Company Information Table 151. Longjin Business Overview Table 152. Longjin Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Longjin Somatostatin Product Portfolio Table 154. Longjin Recent Development Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Somatostatin Distributors List Table 158. Somatostatin Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Somatostatin Product Image Figure 2. Global Somatostatin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Somatostatin Market Size (2021-2032) & (US$ Million) Figure 4. Global Somatostatin Sales (2021-2032) & (K Pcs) Figure 5. Global Somatostatin Average Price (USD/Pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Somatostatin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.25mg/pcs Image Figure 9. 0.75mg/pcs Image Figure 10. 3mg/pcs Image Figure 11. Global Somatostatin Sales by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 12. Global Somatostatin Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Somatostatin Sales Market Share by Type (2021-2032) Figure 14. Global Somatostatin Revenue by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 15. Global Somatostatin Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Somatostatin Revenue Market Share by Type (2021-2032) Figure 17. Hormonal Disorder Image Figure 18. Oncology Image Figure 19. Metabolic Disorder Image Figure 20. Others Image Figure 21. Global Somatostatin Sales by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 22. Global Somatostatin Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Somatostatin Sales Market Share by Application (2021-2032) Figure 24. Global Somatostatin Revenue by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 25. Global Somatostatin Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Somatostatin Revenue Market Share by Application (2021-2032) Figure 27. North America Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 28. North America Somatostatin Sales Market Share by Country (2021-2032) Figure 29. U.S. Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 30. Canada Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 31. Mexico Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 32. Europe Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 33. Europe Somatostatin Sales Market Share by Country (2021-2032) Figure 34. Germany Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 35. France Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 36. U.K. Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 37. Italy Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 38. Netherlands Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 39. Asia Pacific Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 40. Asia Pacific Somatostatin Sales Market Share by Country (2021-2032) Figure 41. China Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 42. Japan Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 43. South Korea Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 44. Southeast Asia Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 45. India Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 46. Australia Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 47. South America, Middle East and Africa Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 48. South America, Middle East and Africa Somatostatin Sales Market Share by Country (2021-2032) Figure 49. Brazil Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 50. South Africa Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 51. Saudi Arabia Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 52. Turkey Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 53. Argentina Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 54. UAE Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 55. Egypt Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 56. Chile Somatostatin Sales and Growth Rate (2021-2032) & (K Pcs) Figure 57. Global Somatostatin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Somatostatin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Somatostatin Revenue (2021-2032) & (US$ Million) Figure 60. North America Somatostatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Somatostatin Revenue (2021-2032) & (US$ Million) Figure 62. Europe Somatostatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Somatostatin Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Somatostatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Somatostatin Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Somatostatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Somatostatin Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Somatostatin Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 0.25mg/pcs
  • 0.75mg/pcs
  • 3mg/pcs
Applications
  • Hormonal Disorder
  • Oncology
  • Metabolic Disorder
  • Others
Companies covered
  • Merck (Schweiz) AG
  • SANOFI-AVENTIS FRANCE
  • Lyomark Pharma GmbH
  • ALFA WASSERMANN S.p.A.
  • Polypeptide Laboratories, Inc
  • SAMARTH
  • UBPL
  • HYBIO
  • TianTaiShan
  • Yangtze River
  • Siyao
  • Shuangcheng
  • Hainan Zhonghe
  • SL PHARM
  • Wuhan Hualong
  • Qingdao Guoda
  • Chengdu Shengnuo
  • Longjin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Somatostatin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Somatostatin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Somatostatin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Somatostatin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Somatostatin Market Dynamics
  1. 2.1 Somatostatin Industry Trends
  2. 2.2 Somatostatin Industry Drivers
  3. 2.3 Somatostatin Industry Opportunities and Challenges
  4. 2.4 Somatostatin Industry Restraints
3 Somatostatin Market by Manufacturers
  1. 3.1 Global Somatostatin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Somatostatin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Somatostatin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Somatostatin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Somatostatin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Somatostatin Manufacturers, Product Type & Application
  7. 3.7 Global Somatostatin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Somatostatin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Somatostatin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Somatostatin Tier 1, Tier 2, and Tier 3
4 Somatostatin Market by Type
  1. 4.1 Somatostatin Type Introduction
  2. 4.1.1 0.25mg/pcs
  3. 4.1.2 0.75mg/pcs
  4. 4.1.3 3mg/pcs
  5. 4.2 Global Somatostatin Sales by Type
  6. 4.2.1 Global Somatostatin Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Somatostatin Sales by Type (2021-2032)
  8. 4.2.3 Global Somatostatin Sales Market Share by Type (2021-2032)
  9. 4.3 Global Somatostatin Revenue by Type
  10. 4.3.1 Global Somatostatin Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Somatostatin Revenue by Type (2021-2032)
  12. 4.3.3 Global Somatostatin Revenue Market Share by Type (2021-2032)
5 Somatostatin Market by Application
  1. 5.1 Somatostatin Application Introduction
  2. 5.1.1 Hormonal Disorder
  3. 5.1.2 Oncology
  4. 5.1.3 Metabolic Disorder
  5. 5.1.4 Others
  6. 5.2 Global Somatostatin Sales by Application
  7. 5.2.1 Global Somatostatin Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Somatostatin Sales by Application (2021-2032)
  9. 5.2.3 Global Somatostatin Sales Market Share by Application (2021-2032)
  10. 5.3 Global Somatostatin Revenue by Application
  11. 5.3.1 Global Somatostatin Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Somatostatin Revenue by Application (2021-2032)
  13. 5.3.3 Global Somatostatin Revenue Market Share by Application (2021-2032)
6 Global Somatostatin Sales by Region
  1. 6.1 Global Somatostatin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Somatostatin Sales by Region (2021-2032)
  3. 6.2.1 Global Somatostatin Sales by Region (2021-2026)
  4. 6.2.2 Global Somatostatin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Somatostatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Somatostatin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Somatostatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Somatostatin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Somatostatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Somatostatin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Somatostatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Somatostatin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Somatostatin Revenue by Region
  1. 7.1 Global Somatostatin Revenue by Region
  2. 7.1.1 Global Somatostatin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Somatostatin Revenue by Region (2021-2026)
  4. 7.1.3 Global Somatostatin Revenue by Region (2027-2032)
  5. 7.1.4 Global Somatostatin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Somatostatin Revenue (2021-2032)
  8. 7.2.2 North America Somatostatin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Somatostatin Revenue (2021-2032)
  11. 7.3.2 Europe Somatostatin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Somatostatin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Somatostatin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Somatostatin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Somatostatin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck (Schweiz) AG
  2. 8.1.1 Merck (Schweiz) AG Company Information
  3. 8.1.2 Merck (Schweiz) AG Business Overview
  4. 8.1.3 Merck (Schweiz) AG Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck (Schweiz) AG Somatostatin Product Portfolio
  6. 8.1.5 Merck (Schweiz) AG Recent Developments
  7. 8.2 SANOFI-AVENTIS FRANCE
  8. 8.2.1 SANOFI-AVENTIS FRANCE Company Information
  9. 8.2.2 SANOFI-AVENTIS FRANCE Business Overview
  10. 8.2.3 SANOFI-AVENTIS FRANCE Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SANOFI-AVENTIS FRANCE Somatostatin Product Portfolio
  12. 8.2.5 SANOFI-AVENTIS FRANCE Recent Developments
  13. 8.3 Lyomark Pharma GmbH
  14. 8.3.1 Lyomark Pharma GmbH Company Information
  15. 8.3.2 Lyomark Pharma GmbH Business Overview
  16. 8.3.3 Lyomark Pharma GmbH Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Lyomark Pharma GmbH Somatostatin Product Portfolio
  18. 8.3.5 Lyomark Pharma GmbH Recent Developments
  19. 8.4 ALFA WASSERMANN S.p.A.
  20. 8.4.1 ALFA WASSERMANN S.p.A. Company Information
  21. 8.4.2 ALFA WASSERMANN S.p.A. Business Overview
  22. 8.4.3 ALFA WASSERMANN S.p.A. Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ALFA WASSERMANN S.p.A. Somatostatin Product Portfolio
  24. 8.4.5 ALFA WASSERMANN S.p.A. Recent Developments
  25. 8.5 Polypeptide Laboratories, Inc
  26. 8.5.1 Polypeptide Laboratories, Inc Company Information
  27. 8.5.2 Polypeptide Laboratories, Inc Business Overview
  28. 8.5.3 Polypeptide Laboratories, Inc Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Polypeptide Laboratories, Inc Somatostatin Product Portfolio
  30. 8.5.5 Polypeptide Laboratories, Inc Recent Developments
  31. 8.6 SAMARTH
  32. 8.6.1 SAMARTH Company Information
  33. 8.6.2 SAMARTH Business Overview
  34. 8.6.3 SAMARTH Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SAMARTH Somatostatin Product Portfolio
  36. 8.6.5 SAMARTH Recent Developments
  37. 8.7 UBPL
  38. 8.7.1 UBPL Company Information
  39. 8.7.2 UBPL Business Overview
  40. 8.7.3 UBPL Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 UBPL Somatostatin Product Portfolio
  42. 8.7.5 UBPL Recent Developments
  43. 8.8 HYBIO
  44. 8.8.1 HYBIO Company Information
  45. 8.8.2 HYBIO Business Overview
  46. 8.8.3 HYBIO Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 HYBIO Somatostatin Product Portfolio
  48. 8.8.5 HYBIO Recent Developments
  49. 8.9 TianTaiShan
  50. 8.9.1 TianTaiShan Company Information
  51. 8.9.2 TianTaiShan Business Overview
  52. 8.9.3 TianTaiShan Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 TianTaiShan Somatostatin Product Portfolio
  54. 8.9.5 TianTaiShan Recent Developments
  55. 8.10 Yangtze River
  56. 8.10.1 Yangtze River Company Information
  57. 8.10.2 Yangtze River Business Overview
  58. 8.10.3 Yangtze River Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yangtze River Somatostatin Product Portfolio
  60. 8.10.5 Yangtze River Recent Developments
  61. 8.11 Siyao
  62. 8.11.1 Siyao Company Information
  63. 8.11.2 Siyao Business Overview
  64. 8.11.3 Siyao Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Siyao Somatostatin Product Portfolio
  66. 8.11.5 Siyao Recent Developments
  67. 8.12 Shuangcheng
  68. 8.12.1 Shuangcheng Company Information
  69. 8.12.2 Shuangcheng Business Overview
  70. 8.12.3 Shuangcheng Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shuangcheng Somatostatin Product Portfolio
  72. 8.12.5 Shuangcheng Recent Developments
  73. 8.13 Hainan Zhonghe
  74. 8.13.1 Hainan Zhonghe Company Information
  75. 8.13.2 Hainan Zhonghe Business Overview
  76. 8.13.3 Hainan Zhonghe Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hainan Zhonghe Somatostatin Product Portfolio
  78. 8.13.5 Hainan Zhonghe Recent Developments
  79. 8.14 SL PHARM
  80. 8.14.1 SL PHARM Company Information
  81. 8.14.2 SL PHARM Business Overview
  82. 8.14.3 SL PHARM Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 SL PHARM Somatostatin Product Portfolio
  84. 8.14.5 SL PHARM Recent Developments
  85. 8.15 Wuhan Hualong
  86. 8.15.1 Wuhan Hualong Company Information
  87. 8.15.2 Wuhan Hualong Business Overview
  88. 8.15.3 Wuhan Hualong Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Wuhan Hualong Somatostatin Product Portfolio
  90. 8.15.5 Wuhan Hualong Recent Developments
  91. 8.16 Qingdao Guoda
  92. 8.16.1 Qingdao Guoda Company Information
  93. 8.16.2 Qingdao Guoda Business Overview
  94. 8.16.3 Qingdao Guoda Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Qingdao Guoda Somatostatin Product Portfolio
  96. 8.16.5 Qingdao Guoda Recent Developments
  97. 8.17 Chengdu Shengnuo
  98. 8.17.1 Chengdu Shengnuo Company Information
  99. 8.17.2 Chengdu Shengnuo Business Overview
  100. 8.17.3 Chengdu Shengnuo Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Chengdu Shengnuo Somatostatin Product Portfolio
  102. 8.17.5 Chengdu Shengnuo Recent Developments
  103. 8.18 Longjin
  104. 8.18.1 Longjin Company Information
  105. 8.18.2 Longjin Business Overview
  106. 8.18.3 Longjin Somatostatin Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Longjin Somatostatin Product Portfolio
  108. 8.18.5 Longjin Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Somatostatin Value Chain Analysis
  2. 9.1.1 Somatostatin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Somatostatin Production Mode & Process
  6. 9.2 Somatostatin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Somatostatin Distributors
  9. 9.2.3 Somatostatin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst